Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA.

Brown JT, Beldorth IJ, Laosinchai-Wolf W, Fahey ME, Jefferson KL, Ruskin AK, Roth JJ, Cai L, Watt CD, Press RD, Yang F, Hedges JB, Andruss BF.

J Mol Diagn. 2019 Jul;21(4):718-733. doi: 10.1016/j.jmoldx.2019.03.002. Epub 2019 Apr 23.

2.

A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib.

Kitamura H, Tabe Y, Ai T, Tsuchiya K, Yuri M, Misawa S, Horii T, Kawaguchi A, Ohsaka A, Kimura S.

PLoS One. 2019 Mar 5;14(3):e0207170. doi: 10.1371/journal.pone.0207170. eCollection 2019.

3.

Analysis of major BCR-ABL1 mRNA by digital polymerase chain reaction is useful for prediction of international scale.

Furuya D, Moriai M, Koizumi Y, Endo T, Asanuma K, Yanagihara N, Takahashi S.

Int J Clin Oncol. 2019 Jul;24(7):871-875. doi: 10.1007/s10147-019-01419-9. Epub 2019 Feb 23.

PMID:
30798394
4.

A kinase profile-adapted drug combination elicits synergistic cooperative effects on leukemic cells carrying BCR-ABL1T315I in Ph+ CML.

Gleixner KV, Sadovnik I, Schneeweiss M, Eisenwort G, Byrgazov K, Stefanzl G, Berger D, Herrmann H, Hadzijusufovic E, Lion T, Valent P.

Leuk Res. 2019 Mar;78:36-44. doi: 10.1016/j.leukres.2018.12.013. Epub 2018 Dec 28.

PMID:
30711891
5.

Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.

Assaf N, El-Cheikh J, Bazarbachi A, Salem Z, Farra C, Chakhachiro Z, Nassif S, Zaatari G, Mahfouz R.

Mol Biol Rep. 2019 Apr;46(2):2003-2011. doi: 10.1007/s11033-019-04649-2. Epub 2019 Jan 30.

PMID:
30701458
6.

Detection of BCR-ABL1 fusion gene transcripts in the saliva of Nigerian patients with chronic myeloid leukemia.

Uzoma IC, Taiwo IA, Nna EO, Durosinmi MA, Ukaejiofo EO.

Niger J Clin Pract. 2019 Jan;22(1):51-55. doi: 10.4103/njcp.njcp_225_18.

7.

Piwi like RNA-mediated gene silencing 1 gene as a possible major player in gastric cancer.

Araújo T, Khayat A, Quintana L, Calcagno D, Mourão R, Modesto A, Paiva J, Lima A, Moreira F, Oliveira E, Souza M, Othman M, Liehr T, Abdelhay E, Gomes R, Santos S, Assumpção P.

World J Gastroenterol. 2018 Dec 21;24(47):5338-5350. doi: 10.3748/wjg.v24.i47.5338.

8.

Clinical Evaluation of Massively Parallel RNA Sequencing for Detecting Recurrent Gene Fusions in Hematologic Malignancies.

Kim B, Lee H, Shin S, Lee ST, Choi JR.

J Mol Diagn. 2019 Jan;21(1):163-170. doi: 10.1016/j.jmoldx.2018.09.002. Epub 2018 Oct 19.

PMID:
30347268
9.

Oncogene mutational analysis in Chinese gastrointestinal stromal tumor patients.

Chen Q, Li R, Zhang ZG, Deng QT, Li K, Wang H, Yang XX, Wu YS.

Onco Targets Ther. 2018 Apr 20;11:2279-2286. doi: 10.2147/OTT.S155214. eCollection 2018.

10.

Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells.

Peter B, Bibi S, Eisenwort G, Wingelhofer B, Berger D, Stefanzl G, Blatt K, Herrmann H, Hadzijusufovic E, Hoermann G, Hoffmann T, Schwaab J, Jawhar M, Willmann M, Sperr WR, Zuber J, Sotlar K, Horny HP, Moriggl R, Reiter A, Arock M, Valent P.

Leukemia. 2018 Apr;32(4):1016-1022. doi: 10.1038/leu.2017.338. Epub 2017 Nov 29.

11.

Analysis of clinically relevant somatic mutations in high-risk head and neck cutaneous squamous cell carcinoma.

Zilberg C, Lee MW, Yu B, Ashford B, Kraitsek S, Ranson M, Shannon K, Cowley M, Iyer NG, Palme CE, Ch'ng S, Low TH, O'Toole S, Clark JR, Gupta R.

Mod Pathol. 2018 Feb;31(2):275-287. doi: 10.1038/modpathol.2017.128. Epub 2017 Oct 6.

12.

Altered expression of genes involved in programmed cell death in primary cultured rat cerebellar granule cells acutely challenged with tetrabromobisphenol A.

Lenart J, Zieminska E, Diamandakis D, Lazarewicz JW.

Neurotoxicology. 2017 Dec;63:126-136. doi: 10.1016/j.neuro.2017.09.014. Epub 2017 Sep 29.

PMID:
28970181
13.

Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?

Chung C, Ma H.

Pharmacotherapy. 2017 Sep;37(9):1052-1072. doi: 10.1002/phar.1977. Epub 2017 Jul 31. Review.

PMID:
28654205
15.

Radotinib induces high cytotoxicity in c-KIT positive acute myeloid leukemia cells.

Heo SK, Noh EK, Kim JY, Jo JC, Choi Y, Koh S, Baek JH, Min YJ, Kim H.

Eur J Pharmacol. 2017 Jun 5;804:52-56. doi: 10.1016/j.ejphar.2017.03.040. Epub 2017 Mar 18.

PMID:
28322836
16.

Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL.

Schjerven H, Ayongaba EF, Aghajanirefah A, McLaughlin J, Cheng D, Geng H, Boyd JR, Eggesbø LM, Lindeman I, Heath JL, Park E, Witte ON, Smale ST, Frietze S, Müschen M.

J Exp Med. 2017 Mar 6;214(3):793-814. doi: 10.1084/jem.20160049. Epub 2017 Feb 11.

17.

High WT1 expression is an early predictor for relapse in patients with acute promyelocytic leukemia in first remission with negative PML-RARa after anthracycline-based chemotherapy: a single-center cohort study.

Yoon JH, Kim HJ, Kwak DH, Park SS, Jeon YW, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS.

J Hematol Oncol. 2017 Jan 23;10(1):30. doi: 10.1186/s13045-017-0404-4.

18.

Opposing roles of KIT and ABL1 in the therapeutic response of gastrointestinal stromal tumor (GIST) cells to imatinib mesylate.

Rausch JL, Boichuk S, Ali AA, Patil SS, Liu L, Lee DM, Brown MF, Makielski KR, Liu Y, Taguchi T, Kuan SF, Duensing A.

Oncotarget. 2017 Jan 17;8(3):4471-4483. doi: 10.18632/oncotarget.13882.

19.

Surgical resection of recurrent gastrointestinal stromal tumor after interruption of long-term nilotinib therapy.

Sugase T, Takahashi T, Ishikawa T, Ichikawa H, Kanda T, Hirota S, Nakajima K, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Takiguchi S, Wakai T, Mori M, Doki Y.

Surg Case Rep. 2016 Dec;2(1):137. Epub 2016 Nov 19.

20.

Detection of CALR Mutation in Clonal and Nonclonal Hematologic Diseases Using Fragment Analysis and Next-Generation Sequencing.

Gardner JA, Peterson JD, Turner SA, Soares BL, Lancor CR, Dos Santos LL, Kaur P, Ornstein DL, Tsongalis GJ, de Abreu FB.

Am J Clin Pathol. 2016 Oct;146(4):448-55. doi: 10.1093/ajcp/aqw129.

PMID:
27686171

Supplemental Content

Loading ...
Support Center